KR20140009016A - Novel pyridine derivatives and method for preparation of intermediate compound for producing sulfonylurea herbicides using the same - Google Patents
Novel pyridine derivatives and method for preparation of intermediate compound for producing sulfonylurea herbicides using the same Download PDFInfo
- Publication number
- KR20140009016A KR20140009016A KR1020130052600A KR20130052600A KR20140009016A KR 20140009016 A KR20140009016 A KR 20140009016A KR 1020130052600 A KR1020130052600 A KR 1020130052600A KR 20130052600 A KR20130052600 A KR 20130052600A KR 20140009016 A KR20140009016 A KR 20140009016A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- alkyl
- fluorine
- chlorine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/28—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
- A01N47/36—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the group >N—CO—N< directly attached to at least one heterocyclic ring; Thio analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pyridine Compounds (AREA)
Abstract
Description
본 발명은 우수한 제초활성을 나타내는 플루오로알킬피리딘-설포닐우레아 유도체를 제조하기 위한 핵심 중간체 화합물의 새로운 제조방법, 그리고 이때 사용된 신규 피리딘 유도체 및 이의 제조방법에 관한 것이다.The present invention relates to a novel process for preparing a core intermediate compound for producing a fluoroalkylpyridine-sulfonylurea derivative exhibiting excellent herbicidal activity, and a novel pyridine derivative and a process for producing the same.
다음 화학식 (1)은 플루세토설푸론(flucetosulfuron)으로 알려진 우수한 제초 활성을 지닌 화합물이다(WO 2002-030921). 선행기술인 일본특허공개 JP 2003-335758에 소개된 방법에 따르면, 화학식 (1)의 화합물은 핵심 중간체인 하기 화학식 (2)의 화합물을 경유하여 합성할 수 있다.The following formula (1) is a compound with excellent herbicidal activity known as flucetosulfuron (WO 2002-030921). According to the method disclosed in the prior art JP 2003-335758, the compound of the formula (1) can be synthesized via a compound of the following formula (2) which is a key intermediate.
상기 식에서,Where
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타내며,A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl Lt; / RTI >
Y는 불소, 염소 또는 브롬 원자를 나타낸다.Y represents a fluorine, chlorine or bromine atom.
즉, 화학식 (1) 화합물의 핵심인 불소기의 도입을 위해서는 Y가 불소인 화학식 (2a)의 중간체가 요구되는데, 이는 하기 반응식 1에 기술한 것처럼, 화학식 (4)의 화합물을 용매 중에서 화학식 (5)의 구리(II) 염과 반응시켜 화학식 (2b)의 화합물을 제조한 후, 이를 용매 중에서 임의로 상전이 촉매의 존재 하에 화학식 (6)의 화합물과 반응시켜 얻어진다.That is, for introduction of the fluorine group which is the core of the compound of the formula (1), an intermediate of the formula (2a) in which Y is fluorine is required which is obtained by reacting the compound of the formula (4) 5) with a copper (II) salt to produce a compound of formula (2b) and then reacting it with a compound of formula (6) optionally in the presence of a phase transfer catalyst in a solvent.
[반응식 1][Reaction Scheme 1]
위 반응식 1에서, A는 전술한 바와 같고, Y'는 염소 또는 브롬 원자를 나타내고, M은 나트륨, 칼륨, 세슘과 같은 알칼리 금속을 나타낸다.In the above Reaction Scheme 1, A is as described above, Y 'represents a chlorine or bromine atom, and M represents an alkali metal such as sodium, potassium or cesium.
이 과정에서 화학식 (4) 화합물의 구조는 목적 화합물인 화학식 (2a)의 골격을 이미 모두 갖춘 상태이지만, 단순히 불소기를 도입하기 위해 두 단계의 추가 반응이 필요하다. 또한, 반응 중에 필연적으로 생성되는 Cu 부산물은 완전 제거가 어려울 뿐 아니라, 다음 단계인 불소화 반응에 영향을 미쳐 불소화 반응의 수율이 저조하게 된다. 한편, 출발물질로 사용된 화학식 (4)의 피리딜케톤 유도체는 문헌(US 5,354,749 A1, Kevin A. Memoli, Tetrahedron Lett. 1996, 37, 3617; 또는 DE 4,304,007 A1)에 공지되어 있거나 여기에 예시된 것과 유사한 방법으로 제조할 수 있는데, 모두 4 단계의 긴 공정을 거쳐야 얻을 수 있다는 단점이 있다.In this process, the structure of the compound of formula (4) is already equipped with the skeleton of formula (2a), which is the target compound, but two additional steps are necessary to simply introduce the fluorine group. In addition, the by-product of Cu inevitably generated during the reaction is not only completely removed but also affects the fluorination reaction in the next step, resulting in a low yield of the fluorination reaction. On the other hand, pyridyl ketone derivatives of the formula (4) used as starting materials are known or can be found in the literature (US 5,354,749 A1, Kevin A. Memoli, Tetrahedron Lett. 1996, 37, 3617; or DE 4,304,007 A1) , All of which are disadvantageous in that they can be obtained only after a long process of four steps.
본 발명자들은 위와 같은 문제점을 고려하여, 화학식 (1)의 플루세토설푸론의 제조에 있어 핵심 중간체인 화학식 (2)의 화합물을 보다 간편하게 제조할 수 있는 방법을 찾고자 집중적인 연구를 수행하였으며, 그 결과 피리딘의 C-2 위치에 C(=O)CHYCH3 기(Y는 불소, 염소 또는 브롬 원자를 나타낸다)를 한 번에 도입하는 방법을 고안하였다. 또한, 이 방법을 활용하여 상용의 출발물질로부터 두 단계 공정만으로 화학식 (2)의 목적화합물을 제조하는 방법을 개발하여 본 발명을 완성하게 되었다.In view of the above problems, the present inventors conducted intensive studies to find a method for more easily preparing a compound of formula (2), which is a key intermediate in the production of flutosulfuron of formula (1) As a result, a method of introducing a C (= O) CHYCH 3 group (Y represents a fluorine, chlorine or bromine atom) at the C-2 position of pyridine was introduced at once. Also, the present invention has been accomplished by developing a method for producing a target compound of formula (2) from a commercially available starting material using only this two step process.
본 발명의 목적은 제초제로서 유용한 플루세토설푸론의 핵심 제조 중간체 화합물의 신규 제조방법을 제공하는 것이다. 본 발명의 다른 목적은 상기 제조 중간체 화합물의 제조에 사용되는 신규의 피리딘 유도체 및 이의 제조방법을 제조하는 것이다.It is an object of the present invention to provide a novel process for the preparation of a key intermediate compound of flucetosulfuron useful as a herbicide. Another object of the present invention is to prepare novel pyridine derivatives used in the preparation of said intermediate compounds and their preparation.
상기 목적을 달성하기 위하여 본 발명에서는, 플루세토설푸론의 제조에 사용되는 하기 화학식 (3)의 피리딘 유도체를 제공한다In order to achieve the above object, the present invention provides a pyridine derivative of the following formula (3) used for the production of flutosulfuron
상기 식에서,Where
D는 불소 또는 염소 원자를 나타내거나, S-A를 나타내며,D represents a fluorine or chlorine atom, represents S-A,
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타낸다.A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl .
E는 브롬 원자 또는 C(=O)CHYCH3 기를 나타내며,E represents a bromine atom or a C (= O) CHYCH 3 group,
Y는 불소, 염소, 브롬 원자를 나타낸다.Y represents fluorine, chlorine or bromine atom.
상기 피리딘 유도체 중에서 바람직한 화합물은 하기 화학식 (3a)의 피리딜 케톤 유도체 및 화학식 (3b)의 2-브로모피리딘 유도체이다.Among the above pyridine derivatives, preferred compounds are pyridyl ketone derivatives of the formula (3a) and 2-bromopyridine derivatives of the formula (3b).
[화학식 3a][Chemical Formula 3]
상기 식에서,Where
D는 불소 또는 염소를 나타내며D represents fluorine or chlorine
Y는 불소, 염소, 브롬 원자를 나타낸다.Y represents fluorine, chlorine or bromine atom.
[화학식 3b](3b)
상기 식에서,Where
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타낸다.A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl .
바람직한 화학식 (3a) 화합물은 1-(3-플루오로피리딘-2-일)-2-플루오로프로판-1-온, 1-(3-클로로피리딘-2-일)-2-플루오로프로판-1-온, 1-(3-클로로피리딘-2-일)-2-클로로프로판-1-온 또는 1-(3-클로로피리딘-2-일)-2-브로모프로판-1-온을 들 수 있다.A preferred compound of formula (3a) is 1- (3-fluoropyridin-2-yl) -2-fluoropropane- 1-one or 1- (3-chloropyridin-2-yl) -2-chloropropan- .
바람직한 화학식 (3b) 화합물은 2-브로모-3-이소프로필티오피리딘, 2-브로모-3-벤질티오피리딘, 2-브로모-3-(4-메톡시벤질) 티오피리딘, 2-브로모-3-(t-부틸필티오)피리딘 또는 2-브로모-사이클로헥실티오피리딘을 들 수 있다.Preferred compounds of formula (3b) are the 2-bromo-3-isopropylthiopyridine, 2-bromo-3-benzylthiopyridine, 2-bromo-3- (4-methoxybenzyl) (T-butylphenylthio) pyridine or 2-bromo-cyclohexylthiopyridine.
본 발명에 따른 화학식 (3a) 화합물은 하기 화학식 (7)의 화합물을 n-부틸 리튬 및 N,N-다이메틸아미노에탄올(DMAE)과 반응시킨 후, 화학식 (8)의 화합물과 반응시키는 것을 특징으로 하는 방법에 의해 제조된다.The compound of formula (3a) according to the present invention is characterized in that the compound of formula (7) is reacted with n-butyllithium and N, N-dimethylaminoethanol (DMAE) . ≪ / RTI >
[화학식 7][Formula 7]
[화학식 8][Formula 8]
상기 식에서,Where
D는 불소 또는 염소 원자를 나타내며, D represents a fluorine or chlorine atom,
Y는 불소, 염소 또는 브롬 원자를 나타내며,Y represents a fluorine, chlorine or bromine atom,
W는 C1-C4-알콕시, C1-C4-다이알킬아민 또는 모폴린 기를 나타낸다.W represents C 1 -C 4 -alkoxy, C 1 -C 4 -dialkylamine or a morpholine group.
또한, 본 발명에 따른 화학식 (3b) 화합물은 화학식 (10)의 화합물을 화학식 (11)의 리튬 아마이드류의 강염기와 반응시킨 후, 화학식 (12)의 친전자체 화합물과 반응시키는 것을 특징으로 하는 방법에 의해 제조된다. The compound of the formula (3b) according to the present invention is obtained by reacting the compound of the formula (10) with a strong base of the lithium amide of the formula (11) and then reacting with the electrophile of the formula (12) .
[화학식 10] [Formula 10]
[화학식 11] [Formula 11]
[화학식 12][Chemical Formula 12]
A-S-XA-S-X
상기 식에서,Where
n = 0 또는 3을 나타내며, n = 0 or 3,
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타내며,A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl Lt; / RTI >
X는 염소 원자 또는 S-A 기를 나타내며, 특히, X가 S-A 기를 나타내는 경우 화학식 (12)의 화합물은 하기 화학식 (12a)의 대칭구조의 다이설파이드 화합물을 이루게 된다.X represents a chlorine atom or an S-A group, and in particular, when X represents an S-A group, the compound of the formula (12) forms a disulfide compound of a symmetrical structure of the following formula (12a).
[화학식 12a] [Chemical Formula 12a]
A-S-S-AA-S-S-A
본 발명의 다른 목적을 달성하기 위한 플루세토설푸론의 제조 중간체인 화학식 (2)의 화합물을 제조하는 방법은, 화학식 (3a)의 화합물을 Cu 촉매, 리간드, 염기 및 용매 조건 하에서 화학식 (9)의 화합물과 반응시키는 것을 특징으로 한다.A method for preparing a compound of formula (2), which is a production intermediate of flutosulfuron for achieving another object of the present invention, comprises reacting a compound of formula (3a) with a compound of formula (9) under Cu catalyst, ligand, With a compound of formula < RTI ID = 0.0 >
[화학식 3a][Chemical Formula 3]
[화학식 9][Chemical Formula 9]
A-SHA-SH
[화학식 2](2)
상기 식에서,Where
D는 불소 또는 염소 원자를 나타내며,D represents a fluorine or chlorine atom,
Y는 불소, 염소 또는 브롬 원자를 나타내며,Y represents a fluorine, chlorine or bromine atom,
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타낸다.A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl .
본 발명에 따른 플루세토설푸론의 제조 중간체인 화학식 (2)의 화합물을 제조하는 다른 방법은, 화학식 (3b)의 화합물을 n-부틸 리튬과 반응시킨 후, 화학식 (8)의 친전자체 화합물과 반응시키는 것을 특징으로 한다.Another method of preparing the compound of formula (2), which is an intermediate for the production of flutosulfuron according to the present invention, comprises reacting the compound of formula (3b) with n-butyllithium, And the reaction is carried out.
[화학식 3b](3b)
[화학식 8] [Formula 8]
[화학식 2](2)
상기 식에서,Where
W는 C1-C4-알콕시, C1-C4-다이알킬아민 또는 모폴린기를 나타내며,W represents C 1 -C 4 -alkoxy, C 1 -C 4 -dialkylamine or a morpholine group,
Y는 불소, 염소 또는 브롬 원자를 나타내며,Y represents a fluorine, chlorine or bromine atom,
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타낸다.
A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl .
이하, 본 발명을 더욱 구체적으로 설명한다.Hereinafter, the present invention will be described more specifically.
본 발명에 따른 플루세토설푸론 제조 중간체인 화학식 (2)의 화합물을 제조하는 방법은 피리딘의 C-2 위치에 C(=O)CHYCH3 기와 피리딘의 C-3 위치에 S-A 기를 도입하는 순서에 따라 방법 A 및 B의 두 가지가 가능하다.The process for preparing the compound of formula (2), which is a flutosulfuron production intermediate according to the present invention, comprises the steps of introducing a C (= O) CHYCH 3 group at the C-2 position of pyridine and an SA group at the C- Two methods, A and B, are possible.
[방법 A][Method A]
화학식 (2)의 화합물의 제조에 있어 본 발명에 따른 첫 번째 방법은, 피리딘의 C-2 위치에 C(=O)CHYCH3 기를 먼저 도입한 후 C-3 위치에 S-A기를 도입하는 방법이다. 즉, 쉽게 입수할 수 있는 화학식 (7)의 화합물을 출발물질로 하여 n-부틸 리튬과 N,N-다이메틸아미노에탄올(DMAE)과 함께 반응시켜 C-2 위치에 선택적으로 리튬을 도입하고 화학식 (8)의 화합물과 반응시킴으로써 C-C 결합을 생성시켜 화학식 (3a)의 신규 화합물을 제조한다. 이후, 화학식 (3a) 화합물을 Cu 촉매, 리간드, 염기 및 용매 조건 하에서 화학식 (9)의 화합물과 반응시키는 짧은 공정 단계로 화학식 (2)의 목표 화합물을 제조할 수 있다. 이때, Y가 염소 또는 브로모 원자인 화학식 (2b)의 화합물은, 상기 반응식 1에 나타낸 바와 같이 용매 중에서 임의로 상전이 촉매의 존재 하에 화학식 (6)의 화합물과 반응시켜 Y가 불소 원자인 화학식 (2a) 화합물로 전환시킬 수 있다.The first method according to the present invention in the preparation of the compound of formula (2) is a method in which a C (═O) CHYCH 3 group is first introduced at the C-2 position of pyridine and then a SA group is introduced at the C-3 position. That is, the compound of formula (7), which is readily available, is reacted with n-butyllithium and N, N-dimethylaminoethanol (DMAE) as a starting material to selectively introduce lithium into the C- With a compound of formula (8) to produce a CC bond to produce a novel compound of formula (3a). The target compound of formula (2) can then be prepared by a short process step in which the compound of formula (3a) is reacted with a compound of formula (9) under Cu catalyst, ligand, base and solvent conditions. The compound of formula (2b) wherein Y is a chlorine or bromo atom can be prepared by reacting a compound of formula (6) with a compound of formula (6) optionally in the presence of a phase transfer catalyst in a solvent as shown in Scheme 1, ) ≪ / RTI > compound.
상기 반응들을 반응식으로 도시하고 구체적인 반응조건에 대해 자세히 설명하면 다음과 같다.The reactions are shown in the form of reaction schemes and the detailed reaction conditions are as follows.
[반응식 2][Reaction Scheme 2]
상기 식에서,Where
D는 불소 또는 염소 원자를 나타내며, D represents a fluorine or chlorine atom,
Y는 불소, 염소 또는 브롬 원자를 나타내며,Y represents a fluorine, chlorine or bromine atom,
W는 C1-C4-알콕시, C1-C4-다이알킬아민 또는 모폴린 기를 나타내며,W represents C 1 -C 4 -alkoxy, C 1 -C 4 -dialkylamine or a morpholine group,
A는 C3-C5-알킬, C3-C6-사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타낸다.A is C 3 -C 5 - alkyl, C 3 -C 6 - cycloalkyl, or represent alkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - 1 to 5 is substituted by a substituent selected from alkoxy or unsubstituted Benzyl.
본 명세서에서 언급된 치환체들은 다음의 의미를 지닌다.The substituents referred to herein have the following meanings.
C3-C5-알킬은 프로필, 이소프로필, 부틸, sec-부틸, 이소부틸, t-부틸, 펜틸, sec-펜틸, t-아밀을 나타내며;C 3 -C 5 -alkyl represents propyl, isopropyl, butyl, sec-butyl, isobutyl, t-butyl, pentyl, sec-pentyl or t-amyl;
C3-C6-사이클로알킬은 사이클로프로필, 사이클로부틸, 사이클로펜틸, 사이클로헥실을 나타내며;C 3 -C 6 -cycloalkyl represents cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl;
C1-C2-알킬은 메틸, 에틸을 나타내며;C 1 -C 2 -alkyl represents methyl, ethyl;
C1-C2-알콕시는 메톡시, 에톡시를 나타낸다.C 1 -C 2 -alkoxy represents methoxy or ethoxy.
Fort 등은 화학식 (7) 화합물의 C-2 위치의 수소 원자를 선택적으로 떼어내어 리튬 이온을 도입하는 방법을 소개하고 있다(문헌; Eur . J. Org . Chem. 2001, 603; Lett . Org . Chem . 2009, 6, 50). 반응식 2에서 첫 단계는 Fort의 방법을 활용하여 화학식 (7)의 화합물을 n-부틸 리튬과 N,N-다이메틸아미노에탄올의 혼합물과 반응시켜 C-2 위치의 수소 원자를 선택적으로 떼어내어 리튬 이온을 도입하는 것이다. 일단, 리튬 이온 상태의 중간체가 생성되면 이를 그대로 같은 반응 용기 내에서 화학식 (8)의 친전자성 화합물과 반응시켜 화학식 (3a)의 신규 중간체를 제조할 수 있다. 이 반응에서 용매는 스스로 반응에 참여하지 않는 통상의 용매를 사용할 수 있으며, 바람직하게는 헥산, 헵탄 등의 알칸류, 디메틸에테르, 디에틸에테르, 메틸 t-부틸에테르, 디메톡시에탄, 테트라하이드로푸란, 디옥산 등의 에테르류를 단독으로 또는 혼합하여 사용한다. 반응 온도는 0 ℃ 내지 -90 ℃의 범위에서 수행 가능하며, -20 ℃ 내지 -90 ℃ 범위가 바람직하며, 더욱 바람직하게는 -40 ℃ 내지 -78 ℃에서 수행한다. 화학식 (8)의 화합물은 상업적으로 직접 입수하거나, 상업적으로 구매 가능한 상응하는 유기산으로부터 통상의 에스테르 합성방법 또는 아마이드 합성방법에 의해 제조할 수 있다. 친전자체인 화학식 (8)의 사용량은 출발물질인 화학식 (7) 화합물 대비 0.9 당량 내지 1.5 당량이 바람직하며, 1.0 당량 내지 1.1 당량이 더욱 바람직하다.Fort et al. Introduced a method for introducing lithium ions out selectively removing the hydrogen atoms of the C-2 position in formula (7) compound (literature;... Eur J. Org Chem 2001, 603;. Lett Org. Chem . 2009, 6 , 50). In the first step in Scheme 2, the compound of formula (7) is reacted with a mixture of n-butyllithium and N, N-dimethylaminoethanol using Fort's method to selectively remove the hydrogen atom at C-2 to form lithium Ions. Once an intermediate in the lithium ion state is generated, it can be reacted with an electrophilic compound of the formula (8) in the same reaction vessel to prepare a novel intermediate of the formula (3a). The solvent used in this reaction may be a conventional solvent that does not participate in the reaction itself, preferably an alkane such as hexane or heptane, an ether such as dimethyl ether, diethyl ether, methyl t-butyl ether, dimethoxyethane, tetrahydrofuran , Dioxane and the like are used singly or in combination. The reaction temperature may be in the range of 0 ° C to -90 ° C, preferably in the range of -20 ° C to -90 ° C, more preferably -40 ° C to -78 ° C. Compounds of formula (8) can be obtained commercially or obtained from commercially available corresponding organic acids by conventional ester synthesis methods or amide synthesis methods. The amount of the electron donor represented by formula (8) is preferably 0.9 equivalents to 1.5 equivalents, more preferably 1.0 equivalents to 1.1 equivalents, relative to the compound represented by formula (7) as a starting material.
두 번째 단계에서는, 화학식 (3a)의 신규 중간체를 염기, 용매, 리간드 및 구리 촉매 하에 화학식 (9)의 화합물과 반응시켜 C-S 결합을 생성시키는 것에 의해 화학식 (2)의 목적 화합물을 제조할 수 있다. 이때 염기는 탄산 세슘, 탄산 칼륨, 탄산 수소나트륨 등의 무기염기, 또는 트리에틸아민, 피리딘, 디아자바이사이클로운데칸(DBU) 등의 유기염기를 사용할 수 있다. 바람직하게는 탄산 세슘, 탄산 칼륨, 트리에틸아민을, 더욱 바람직하게는 탄산 세슘 또는 탄산 칼륨을 사용할 수 있다. Cu 촉매로는 산화구리(Cu2O), 요오드화구리(CuI), 염화구리(CuCl), 브롬화구리(CuBr)를 사용할 수 있으며, 바람직한 것은 산화구리(Cu2O) 또는 요오드화구리(CuI)이다. Cu 촉매의 사용량은 0.01 당량 내지 0.5 당량, 바람직하게는 0.05 당량 내지 0.2 당량까지 사용할 수 있다. 용매는 다이메틸설폭사이드(DMSO), 다이메틸포름아마이드(DMF), 다이메틸아세트아마이드(DMAC), N-메틸피롤리딘(NMP) 등 비양자성 극성용매류를 사용하거나 벤젠, 톨루엔, 자일렌 등 방향족 용매를 사용할 수 있다. 바람직한 용매는 다이메틸설폭사이드, 다이메틸포름아마이드, N-메틸피롤리딘 또는 톨루엔이고, 더욱 바람직하게는 다이메틸설폭사이드 또는 다이메틸포름아마이드를 사용할 수 있다. 반응 온도는 0 ℃ 내지 60 ℃의 범위에서 실시 가능하며, 바람직하게는 15 ℃ 내지 25 ℃ 범위에서 수행한다. 리간드로는 2-(에톡시카보닐)사이클로헥산온, 1,2-사이클로헥산다이아민, N,N-다이에틸아민 등을 사용할 수 있다.In a second step, the desired compound of formula (2) can be prepared by reacting a novel intermediate of formula (3a) with a compound of formula (9) under base, solvent, ligand and copper catalysts to produce a CS bond . The base may be an inorganic base such as cesium carbonate, potassium carbonate or sodium hydrogencarbonate or an organic base such as triethylamine, pyridine or diazabicyclo dodecane (DBU). Cesium carbonate, potassium carbonate and triethylamine are preferable, and cesium carbonate or potassium carbonate is more preferably used. As the Cu catalyst, copper oxide (Cu 2 O), copper iodide (CuI), copper chloride (CuCl) and copper bromide (CuBr) can be used, and copper oxide (Cu 2 O) or copper iodide . The amount of the Cu catalyst to be used may be 0.01 to 0.5 equivalents, preferably 0.05 to 0.2 equivalents. The solvent may be an aprotic polar solvent such as dimethylsulfoxide (DMSO), dimethylformamide (DMF), dimethylacetamide (DMAC) or N-methylpyrrolidine (NMP), or a solvent such as benzene, toluene, xylene And the like can be used. Preferred solvents are dimethylsulfoxide, dimethylformamide, N-methylpyrrolidine or toluene, more preferably dimethylsulfoxide or dimethylformamide. The reaction temperature may be in the range of 0 ° C to 60 ° C, preferably in the range of 15 ° C to 25 ° C. As the ligand, 2- (ethoxycarbonyl) cyclohexanone, 1,2-cyclohexanediamine, N, N-diethylamine and the like can be used.
[방법 B][Method B]
화학식 (2)의 화합물을 제조하는 본 발명에 따른 두 번째 방법은, 피리딘의 C-3 위치에 S-A기를 먼저 도입한 후 C-2 위치에 C(=O)CHYCH3 기를 도입하는 방법이다. 즉, 쉽게 입수할 수 있는 화학식 (10)의 출발물질을 적절한 용매 하에 온도 -40 내지 -90 ℃에서 화학식 (11)의 리튬 아마이드류의 강염기와 반응시켜 C-3 위치에 리튬을 도입하고 화학식 (12)의 친전자체 화합물과 반응시켜 화학식 (3b)의 신규 중간체를 합성한다. 이어서, 화학식 (3b) 화합물로부터 브롬-리튬 교환반응을 통해 C-2 위치에 리튬을 도입하고 화학식 (8)의 친전자체 화합물과 반응시키는 것에 의해 짧은 공정단계로 화학식 (2)의 목표 화합물을 제조할 수 있다.A second method according to the present invention for preparing the compound of formula (2) is a method of introducing C (= O) CHYCH 3 group at C-2 position after first introduction of SA group at C-3 position of pyridine. That is, the readily available starting material of formula (10) is reacted with a strong base of lithium amides of formula (11) at -40 to -90 < 0 > C in an appropriate solvent, introducing lithium at the C- 12) with an electrophilic compound of formula (3b) to synthesize a novel intermediate of formula (3b). Subsequently, lithium is introduced into the C-2 position from the compound of formula (3b) via a bromine-lithium exchange reaction and reacted with the electrophile of formula (8) to give the target compound of formula (2) can do.
상기 반응들을 반응식으로 도시하고 구체적인 반응조건에 대해 자세히 설명하면 다음과 같다.The reactions are shown in the form of reaction schemes and the detailed reaction conditions are as follows.
[반응식 3]Scheme 3
상기 식에서 n = 0 또는 3을 나타내고;Wherein n represents 0 or 3;
X는 염소 원자 또는 S-A 기를 나타내며, 특히, X가 S-A 기를 나타내는 경우 화학식 (12)의 화합물은 대칭구조의 다이설파이드 화합물을 이루게 되고,X represents a chlorine atom or an S-A group, and particularly when X represents an S-A group, the compound of the formula (12) forms a disulfide compound of a symmetrical structure,
Y는 불소, 염소 또는 브롬 원자를 나타내며,Y represents a fluorine, chlorine or bromine atom,
W는 C1-C4-알콕시, C1-C4-다이알킬아민 또는 모폴린 기를 나타내며,W represents C 1 -C 4 -alkoxy, C 1 -C 4 -dialkylamine or a morpholine group,
A는 C3-C5-알킬, C3-C6-사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타낸다.A is C 3 -C 5 - alkyl, C 3 -C 6 - cycloalkyl, or represent alkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - 1 to 5 is substituted by a substituent selected from alkoxy or unsubstituted Benzyl.
반응식 3의 첫 단계에서는 화학식 (10)의 화합물을 화학식 (11)의 리튬 아마이드류의 강염기와 저온에서 반응시켜 피리딘의 C-3 위치에 리튬을 도입한다. 이때 화학식 (11)의 강염기는 리튬 다이이소프로필아마이드(n=0)또는 리튬 2,2,6,6-테트라메틸피페라자이드(n=3)을 사용할 수 있다. 이 반응에서 용매는 스스로 반응에 참여하지 않는 통상의 용매를 사용할 수 있으며, 바람직하게는 헥산, 헵탄 등 알칸류, 디메틸에테르, 디에틸에테르, 메틸 t-부틸에테르, 디메톡시에탄, 테트라하이드로푸란, 2-메틸테트라하이드로푸란, 디옥산 등의 에테르류를 단독으로 또는 혼합하여 사용한다. 반응온도는 -40 ℃ 내지 -90 ℃의 범위에서 수행가능하며, -60 ℃ 내지 -90 ℃ 범위가 바람직하고, -78 ℃ 내지 -90 ℃ 범위가 더욱 바람직하다. 일단, 리튬 이온 상태의 중간체가 생성되면 이를 그대로 같은 반응 용기 내에서 화학식 (12)의 친전자성 화합물과 반응시켜 화학식 (3b)의 신규 화합물을 제조할 수 있다. 이때 화학식 (12)의 다이설파이드 또는 설페닐클로라이드 화합물은 상업적으로 입수하거나, 알려진 합성방법에 의해 제조할 수 있다(문헌: Gillis, H. M., Greene, L., Thompson, A. Synlett, 2009, 112; Leino, R., Lonngvist, J.-E. Tetrahedron Lett. 2004, 8489). 친전자체인 화학식 (12)의 사용량은 출발물질인 화학식 (10)의 화합물 대비 0.9 당량 내지 1.5 당량이 바람직하고, 1.0 당량 내지 1.1 당량이 더욱 바람직하다. 용매는 첫 단계에서 사용한 용매를 변경하지 않고 그대로 사용한다.In the first step of Scheme 3, the compound of formula (10) is reacted with a strong base of the lithium amide of formula (11) at low temperature to introduce lithium at the C-3 position of pyridine. At this time, lithium diisopropylamide ( n = 0) or lithium 2,2,6,6-tetramethylpiperazide ( n = 3) can be used as the strong base of formula (11). The solvent used in this reaction may be a conventional solvent that does not participate in the reaction itself. Preferred solvents include alkanes such as hexane and heptane, dimethyl ether, diethyl ether, methyl t-butyl ether, dimethoxyethane, tetrahydrofuran, Ethers such as 2-methyltetrahydrofuran, dioxane and the like are used alone or in combination. The reaction temperature may be in the range of -40 캜 to -90 캜, preferably in the range of -60 캜 to -90 캜, and more preferably in the range of -78 캜 to -90 캜. Once a lithium ion intermediate is formed, it can be reacted with an electrophilic compound of formula (12) in the same reaction vessel to produce a novel compound of formula (3b). The disulfide or sulfenyl chloride compound of formula (12) is commercially available or can be prepared by known synthetic methods (Gillis, HM, Greene, L., Thompson, A. Synlett , 2009, 112; Leino, R., Lonngvist, J.-E. Tetrahedron Lett . 2004, 8489). The amount of the electron donor represented by formula (12) is preferably 0.9 equivalents to 1.5 equivalents, more preferably 1.0 equivalents to 1.1 equivalents, relative to the compound of formula (10) as a starting material. The solvent used in the first step is not changed and is used as it is.
다음 단계에서는, 본 발명에 따라 제조된 화학식 (3b)의 신규 화합물을 적절한 용매에서 n-부틸 리튬과 반응시켜 브롬-리튬 교환 반응을 통해 C-2 위치에 리튬을 도입한 후, 화학식 (8)의 친전자체 화합물과 반응시키는 짧은 공정 단계를 통해 화학식 (2)의 화합물을 제조할 수 있다. 이 반응에서 용매는 스스로 반응에 참여하지 않는 통상의 용매를 사용할 수 있으며, 바람직하게는 헥산, 헵탄 등의 알칸류, 디메틸에테르, 디에틸에테르, 메틸 t-부틸에테르, 디메톡시에탄, 테트라하이드로푸란, 2-메틸테트라하이드로푸란, 디옥산 등의 에테르류, 톨루엔, 자일렌 등 방향족 탄화수소류를 단독으로 또는 혼합하여 사용한다. 반응온도는 -40 ℃ 내지 -90 ℃의 범위에서 수행 가능하며, -50 ℃ 내지 -80 ℃ 범위가 바람직하고 -60 ℃ 내지 -78 ℃가 더욱 바람직하다. 일단, C-2 위치에 리튬이 도입되면 화학식 (8)의 친전자체 화합물과의 반응은 동일 용매 및 동일 온도 하에서 수행된다. 친전자체인 화학식 (8) 화합물의 사용량은 출발물질인 화학식 (10) 화합물 대비 1.0 당량 내지 1.5 당량이 바람직하며, 1.0 당량 내지 1.1 당량이 더욱 바람직하다.In the next step, a novel compound of formula (3b) prepared according to the present invention is reacted with n-butyllithium in a suitable solvent to introduce lithium at the C-2 position via a bromine-lithium exchange reaction, Lt; / RTI > can be prepared via a short process step in which the compound of formula (2) is reacted with an electrophile of formula < RTI ID = 0.0 > The solvent used in this reaction may be a conventional solvent that does not participate in the reaction itself, preferably an alkane such as hexane or heptane, an ether such as dimethyl ether, diethyl ether, methyl t-butyl ether, dimethoxyethane, tetrahydrofuran , Ethers such as 2-methyltetrahydrofuran and dioxane, aromatic hydrocarbons such as toluene and xylene are used alone or in combination. The reaction temperature can be -40 ° C to -90 ° C, preferably -50 ° C to -80 ° C, and more preferably -60 ° C to -78 ° C. Once lithium is introduced at the C-2 position, the reaction with the electrophilic compound of formula (8) is carried out under the same solvent and at the same temperature. The amount of the compound of the formula (8) used as the proton electron is preferably 1.0 equivalents to 1.5 equivalents, more preferably 1.0 equivalents to 1.1 equivalents, relative to the compound of the formula (10) as a starting material.
본 발명에 따른 화학식 (2) 화합물의 제조에 사용되는 화학식 (3)의 화합물은 신규 구조의 피리딘 유도체로서, 본 발명에서는 화학식 (3)의 화합물, 특히 상기 반응식 2 및 3에서 사용되는 화학식 (3a) 및 (3b) 화합물과 이들의 제조방법을 제공한다.The compound of formula (3) used in the preparation of the compound of formula (2) according to the present invention is a pyridine derivative of novel structure. In the present invention, the compound of formula (3) ) And (3b) compounds and a process for their preparation.
[화학식 3](3)
상기 식에서,Where
D는 불소 또는 염소 원자를 나타내거나, S-A를 나타내며,D represents a fluorine or chlorine atom, represents S-A,
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타낸다.A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl .
E는 브롬 원자 또는 C(=O)CHYCH3 기를 나타내며,E represents a bromine atom or a C (= O) CHYCH 3 group,
Y는 불소, 염소, 브롬 원자를 나타낸다.Y represents fluorine, chlorine or bromine atom.
여기에서, D가 불소 또는 염소 원자를 나타내고, E는 C(=O)CHYCH3 기를 나타낼 때 화학식 (3a)의 피리딜 케톤 유도체가 되고. D가 S-A를 나타내고, E는 브롬 원자를 나타낼 때 화학식 (3b)의 2-브로모피리딘 유도체가 된다.Wherein D is a fluorine or chlorine atom and E is a pyridyl ketone derivative of formula (3a) when it represents a C (= O) CHYCH 3 group. D is SA, and E is a 2-bromopyridine derivative of formula (3b) when it represents a bromine atom.
[화학식 3a][Chemical Formula 3]
상기 식에서,Where
D는 불소 또는 염소를 나타내며D represents fluorine or chlorine
Y는 불소, 염소, 브롬 원자를 나타낸다.Y represents fluorine, chlorine or bromine atom.
바람직한 화학식 (3a) 화합물은 1-(3-플루오로피리딘-2-일)-2-플루오로프로판-1-온, 1-(3-클로로피리딘-2-일)-2-플루오로프로판-1-온, 1-(3-클로로피리딘-2-일)-2-클로로프로판-1-온 또는 1-(3-클로로피리딘-2-일)-2-브로모프로판-1-온을 들 수 있으며, D가 염소 원자이고, Y가 불소 원자인 화합물이 더욱 바람직하다.A preferred compound of formula (3a) is 1- (3-fluoropyridin-2-yl) -2-fluoropropane- 1-one or 1- (3-chloropyridin-2-yl) -2-chloropropan- , D is a chlorine atom, and Y is a fluorine atom.
[화학식 3b](3b)
상기 식에서,Where
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타낸다.A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl .
상기 본 발명에 따른 화학식 (3b)의 신규 화합물 중에서도 바람직한 화합물은 A가 이소프로필, sec-부틸, t-부틸, sec-펜틸, t-아밀, 사이클로헥실, 또는 벤질을 나타내는 신규 화합물로서, 2-브로모-3-이소프로필티오피리딘, 2-브로모-3-벤질티오피리딘, 2-브로모-3-(4-메톡시벤질)티오피리딘, 2-브로모-3-(t-부틸티오)피리딘 또는 2-브로모-사이클로헥실티오피리딘을 들 수 있다. 더욱 바람직한 화학식 (3b) 화합물은 A가 이소프로필, t-부틸 또는 벤질을 나타내는 것이다.Among the novel compounds of formula (3b) according to the present invention, the preferred compounds are the novel compounds wherein A represents isopropyl, sec-butyl, t-butyl, sec-pentyl, t-amyl, cyclohexyl, Bromo-3-isopropylthiopyridine, 2-bromo-3-benzylthiopyridine, 2-bromo-3- (4-methoxybenzyl) ) Pyridine or 2-bromo-cyclohexylthiopyridine. More preferred compounds of formula (3b) are those in which A represents isopropyl, t-butyl or benzyl.
본 발명에 따른 신규 피리딜 케톤 유도체 또는 2-브로모피리딘 유도체 화합물을 이용하는 방법에 의하면, 플루세토설푸론의 제조 중간체인 화학식 (2)의 화합물을 보다 단순한 공정 단계를 통해 종래의 방법과 동등하거나 이보다 높은 수율로 제조할 수 있다.According to the method using the novel pyridyl ketone derivative or 2-bromopyridine derivative compound according to the present invention, the compound of formula (2), which is a production intermediate of flutosulfuron, is equivalent to the conventional method through a simpler process step Can be produced at a higher yield.
이하, 본 발명을 하기 제조예 및 실시예에 의거하여 보다 구체적으로 설명한다. 그러나, 이들 제조예 및 실시예는 본 발명에 대한 이해를 돕기 위한 것일 뿐, 어떤 의미로든 본 발명의 범위가 이들에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail based on the following Preparation Examples and Examples. However, these preparation examples and examples are only for the understanding of the present invention, and the scope of the present invention is not limited by them in any sense.
실시예Example 1 One :: 화학식 (3a) 화합물의 합성Synthesis of Compound (3a)
[화학식 3a][Chemical Formula 3]
실시예Example 1-1: 1-(3- 1-1: 1- (3- 클로로피리딘Chloropyridine -2-일)-2-Yl) -2- 플루오로프로판Fluoropropane -1-온의 합성(D = 염소, Y = 불소)-1-one (D = chlorine, Y = fluorine)
질소 하에서 헥산(40 mL)과 N,N-다이메틸아미노에탄올(3.14 g, 35.2 mmol)을 투입하고 -5 ℃까지 냉각하였다. 반응용액에 n-부틸 리튬(2.5 M 헥산 용액, 70 mmol)을 천천히 적가하였다. 1 시간 동안 교반한 후 -41 ℃까지 냉각하고 3-클로로피리딘(2.04 g, 18 mmol)을 헥산에 녹여 천천히 적가하였다. 적가가 완료된 후 -78 ℃까지 냉각하고, 2-플루오로프로피온산 모폴린 아마이드(5.64 g, 35 mmol)를 헥산에 녹여 천천히 적가하였다. 2 시간 교반한 후 -20 ℃까지 승온하고 프로피온산(9.13 g, 123 mmol)를 천천히 적가하여 반응을 종결시켰다. 반응용액을 0 ℃까지 승온하여 물을 투입하고 에틸아세테이트로 추출하였다. 추출한 유기층은 황산마그네슘으로 수분을 제거하고 증류하여 용매를 제거하였다. 반응 혼합물을 컬럼크로마토그라피로 분리하여 표제화합물을 얻었다(2.29 g, 68%).Under nitrogen, hexane (40 mL) and N, N-dimethylaminoethanol (3.14 g, 35.2 mmol) were added and cooled to -5 ° C. To the reaction solution, n-butyllithium (2.5 M hexane solution, 70 mmol) was slowly added dropwise. After stirring for 1 hour, the reaction mixture was cooled to -41 DEG C, and 3-chloropyridine (2.04 g, 18 mmol) was dissolved in hexane and slowly added dropwise. After the dropwise addition was completed, the reaction mixture was cooled to -78 deg. C, and 2-fluoropropionic acid morpholine amide (5.64 g, 35 mmol) was dissolved in hexane and slowly added dropwise. After stirring for 2 hours, the temperature was raised to -20 ° C, and propionic acid (9.13 g, 123 mmol) was slowly added dropwise to terminate the reaction. The reaction solution was heated to 0 ° C, water was added, and the mixture was extracted with ethyl acetate. The organic layer was extracted with magnesium sulfate and distilled to remove the solvent. The reaction mixture was separated by column chromatography to give the title compound (2.29 g, 68%).
1H NMR (CDCl3, δ): 8.54 (dd, J=1.2, 4.3 Hz, 1H), 7.83 (dd, J=1.2, 8.0 Hz, 1H), 7.42 (dd, J=4.3, 8.0 Hz, 1H), 6.05 (dq, J=6.7, 48.9 Hz, 1H), 1.63 (dd, J=6.7, 23.8 Hz, 3H) 1 H NMR (CDCl 3, δ ): 8.54 (dd, J = 1.2, 4.3 Hz, 1H), 7.83 (dd, J = 1.2, 8.0 Hz, 1H), 7.42 (dd, J = 4.3, 8.0 Hz, 1H ), 6.05 (dq, J = 6.7,48.9 Hz, 1H), 1.63 (dd, J = 6.7,23.8 Hz,
실시예Example 1-2: 1-(3- 1-2: 1- (3- 플루오로피리딘Fluoropyridine -2-일)-2-Yl) -2- 플루오로프로판Fluoropropane -1-온의 합성(D = 불소, Y = 불소)-L-one (D = fluorine, Y = fluorine)
실시예 1-1의 방법과 동일하게 진행하되, 출발물질을 3-클로로피리딘 대신 3-플루오로피리딘(1.75 g, 18 mmol)을 사용하여 반응시켜 표제 화합물을 얻었다(2.00 g, 65%). Proceeding as in Example 1-1, the starting material was reacted with 3-fluoropyridine (1.75 g, 18 mmol) instead of 3-chloropyridine to give the title compound (2.00 g, 65%).
1H NMR (CDCl3, δ): 8.51-8.50 (m, 1H), 7.60-7.54 (m, 2H), 6.15 (dq, J=6.7, 48.9 Hz, 1H), 1.67 (dd, J=6.7, 23.8 Hz, 3H) 1 H NMR (CDCl 3, δ ): 8.51-8.50 (m, 1H), 7.60-7.54 (m, 2H), 6.15 (dq, J = 6.7, 48.9 Hz, 1H), 1.67 (dd, J = 6.7, 23.8 Hz, 3H)
실시예Example 1-3: 1-(3- 1-3: 1- (3- 클로로피리딘Chloropyridine -2-일)-2-Yl) -2- 클로로프로판Chloropropane -1-온의 합성(D=염소, Y= 염소)1-one (D = chlorine, Y = chlorine)
3-클로로피리딘(2.04 g, 18 mmol)을 출발물질로 하여 실시예 1-1의 방법과 동일하게 진행하되, 친전자체로서 2-플루오로프로피온산 모폴린아마이드 대신 에틸 2-클로로프로피오네이트(4.78 g, 35 mmol)를 사용하여 반응시켜 표제 화합물을 얻었다(1.91 g, 52%).Chloropyridine (2.04 g, 18 mmol) as a starting material, ethyl 2-chloropropionate (4.78 g, g, 35 mmol) to give the title compound (1.91 g, 52%).
1H NMR (CDCl3, δ): 8.55 (d, J=4.9 Hz, 1H), 7.84 (d, J=8.6 Hz, 1H), 7.41 (dd, J=4.3, 8.0 Hz, 1H), 5.73 (q, J=6.7 Hz, 1H), 1.74 (d, J=6.8 Hz, 3H)
1 H NMR (CDCl 3, δ ): 8.55 (d, J = 4.9 Hz, 1H), 7.84 (d, J = 8.6 Hz, 1H), 7.41 (dd, J = 4.3, 8.0 Hz, 1H), 5.73 ( q, J = 6.7 Hz, 1H), 1.74 (d, J = 6.8 Hz, 3H)
실시예Example 2 2 :: 화학식 (3b) 화합물의 합성Synthesis of compound of formula (3b)
실시예Example 2-1: 2- 2-1: 2- 브로모Bromo -3--3- 이소프로필티오피리딘의Of isopropylthiopyridine 합성( synthesis( 다이설파이드Disulfide 방법) Way)
2,2,6,6-테트라메틸피페리딘(3.94 g, 28 mmol)의 테트라하이드로푸란(12 mL) 용액에 n-부틸 리튬(2.5 M 헥산 용액, 28 mmol)을 -20 ℃에서 적가하고 약 1 시간 동안 교반하였다. 온도를 -78 ℃까지 냉각하고 2-브로모피리딘(3.95 g, 25 mmol)을 적가하여 슬러리의 생성을 관찰한 후, 온도를 계속 유지하면서 다이이소프로필 다이설파이드(3.76 g, 25 mmol)의 테트라하이드로푸란 용액을 서서히 적가하였다. 적가 완료 후 30 분간 더 교반하고 반응 혼합물에 에탄올(2 mL)을 투입하고 상온으로 승온하였다. 증류수를 투입한 다음 층분리를 실시하고, 유기층을 2 N 수산화나트륨, 증류수, 2 N 염산의 순서대로 세척하고 감압증류를 실시하였다. 반응 혼합물을 컬럼크로마토그라피로 분리하여 표제의 화합물을 얻었다(4.80 g, 83%).N-Butyl lithium (2.5 M hexane solution, 28 mmol) was added dropwise to a tetrahydrofuran (12 mL) solution of 2,2,6,6-tetramethylpiperidine (3.94 g, 28 mmol) And stirred for about 1 hour. The temperature was then cooled to -78 ° C and 2-bromopyridine (3.95 g, 25 mmol) was added dropwise to observe the formation of the slurry. The temperature was maintained at this temperature while diisopropyl disulfide (3.76 g, 25 mmol) The hydrofuran solution was slowly added dropwise. After completion of dropwise addition, the mixture was further stirred for 30 minutes, ethanol (2 mL) was added to the reaction mixture, and the temperature was raised to room temperature. Distilled water was added thereto, followed by layer separation, and the organic layer was washed with 2 N sodium hydroxide, distilled water and 2 N hydrochloric acid in this order and subjected to vacuum distillation. The reaction mixture was separated by column chromatography to give the title compound (4.80 g, 83%).
1H NMR (CDCl3, δ): 8.16 (dd, J=2.0, 4.8 Hz, 1H), 7.58 (dd, J=2.0, 7.6 Hz, 1H), 7.23 (dd, J=4.8, 7.6 Hz, 1H), 3.50 (m, J=8.0 Hz, 1H), 1.38 (d, J=8.0 Hz, 6H) 1 H NMR (CDCl 3 , δ): 8.16 (dd, J = 2.0, 4.8 Hz, 1H), 7.58 (dd, J = 2.0, 7.6 Hz, 1H), 7.23 (dd, J = 4.8, 7.6 Hz, 1H ), 3.50 (m, J = 8.0 Hz, 1H), 1.38 (d, J = 8.0 Hz, 6H)
실시예Example 2-2 내지 2-5 2-2 to 2-5
실시예 2-1의 방법과 동일하게 진행하되, 다이이소프로필 다이설파이드 대신 각각 아래 표 1에 나타낸 A에 상응하는 다이설파이드 친전자체를 사용하여 반응시켜 각각의 표제 화합물을 얻었다.Proceeding in the same manner as in Example 2-1 except that disilicide electrophiles corresponding to A shown in Table 1 were used instead of diisopropyl disulfide to obtain the respective title compounds.
실시예Example 2-6: 2- 2-6: 2- 브로모Bromo -3--3- 이소프로필티오피리딘의Of isopropylthiopyridine 합성( synthesis( 설페닐클로라이드Sulfhenyl chloride 방법) Way)
2,2,6,6-테트라메틸피페리딘(3.94 g, 28 mmol)의 테트라하이드로푸란(12 mL) 용액에 n-부틸 리튬(2.5 M 헥산 용액, 28 mmol)을 -20 ℃에서 적가하고 약 1 시간 동안 교반하였다. 온도를 -78 ℃까지 더 냉각하고 2-브로모피리딘(3.95 g, 25 mmol)을 적가하여 슬러리의 생성을 관찰한 후, 온도를 계속 유지하면서 헥산(4 mL)에 녹인 이소프로필 설페닐클로라이드(3.10 g, 28 mmol) 용액을 서서히 적가하였다. 적가 완료 후 30 분간 더 교반하고 반응 혼합물에 에탄올(2 mL)을 투입하여 상온으로 승온하였다. 증류수를 투입한 다음 층분리를 실시하고, 유기층을 2 N 수산화나트륨, 증류수, 2 N 염산 순서대로 씻어주고 감압증류를 실시하였다. 반응 혼합물을 컬럼크로마토그라피로 분리하여 실시예 2-1과 동일한 표제 화합물을 얻었다(3.46 g, 60%).
N-Butyl lithium (2.5 M hexane solution, 28 mmol) was added dropwise to a tetrahydrofuran (12 mL) solution of 2,2,6,6-tetramethylpiperidine (3.94 g, 28 mmol) And stirred for about 1 hour. The temperature was further cooled to -78 < 0 > C and 2-bromopyridine (3.95 g, 25 mmol) was added dropwise to observe the formation of the slurry. Then, isopropylsulfenylchloride 3.10 g, 28 mmol) in THF (20 mL) was slowly added dropwise. After completion of the dropwise addition, the reaction mixture was further stirred for 30 minutes, ethanol (2 mL) was added to the reaction mixture, and the temperature was raised to room temperature. Distilled water was added thereto, and layer separation was carried out. The organic layer was washed with 2 N sodium hydroxide, distilled water and 2 N hydrochloric acid in this order and subjected to vacuum distillation. The reaction mixture was separated by column chromatography to obtain the same title compound as in Example 2-1 (3.46 g, 60%).
실시예Example 3 3 : 화학식 (2) 화합물의 합성(방법 A): Synthesis of Compound (2) (Method A)
실시예Example 3-1: 1-(3- 3-1: 1- (3- 벤질설파닐피리딘Benzylsulfanylpyridine -2-일)-2-Yl) -2- 플루오로프로판Fluoropropane -1-온의 합성Synthesis of -1-one
1-(3-클로로피리딘-2-일)-2-플루오로프로판-1-온(1.87 g, 10 mmol)을 다이메틸설폭사이드(20 mL)에 녹여 벤질 멀캅탄(1.37 g, 11 mmol), 산화 구리(70 ㎎, 0.5 mmol), 2-(에톡시카보닐)사이클로헥산온(0.17 g, 1 mmol) 및 탄산 칼륨(2.76 g, 20 mmol)을 투입하고 상온에서 약 2 시간 동안 교반하였다. 반응이 완료되면 에틸아세테이트(100 mL)와 물(50 mL)을 투입하고 교반한 다음 층분리를 실시하였다. 유기층을 암모니아수 용액과 물의 순서로 세척하고 감압증류를 실시하였다. 반응 혼합물을 컬럼크로마토그라피로 분리하여 표제의 화합물을 얻었다(3.35 g, 61%).(1.87 g, 10 mmol) was dissolved in dimethylsulfoxide (20 mL) and benzylmercaptan (1.37 g, 11 mmol) was dissolved in dichloromethane , Potassium carbonate (70 mg, 0.5 mmol), 2- (ethoxycarbonyl) cyclohexanone (0.17 g, 1 mmol) and potassium carbonate (2.76 g, 20 mmol) were added and stirred at room temperature for about 2 hours . When the reaction was completed, ethyl acetate (100 mL) and water (50 mL) were added and stirred, followed by layer separation. The organic layer was washed with ammonia water solution and water in this order and subjected to vacuum distillation. The reaction mixture was separated by column chromatography to give the title compound (3.35 g, 61%).
H NMR (CDCl3, δ): 8.38(dd,J = 1.2, 4.4 Hz, 1H), 7.74(dd, J = 1.2, 8.4 Hz, 1H), 7.45∼7.27(m, 6H), 6.27 (dq, J = 6.8, 49.6 Hz, 1H), 4.16(s, 2H), 1.66(dd, J = 6.8, 23.6 Hz, 3H)
H NMR (CDCl 3, δ) : 8.38 (dd, J = 1.2, 4.4 Hz, 1H), 7.74 (dd, J = 1.2, 8.4 Hz, 1H), 7.45~7.27 (m, 6H), 6.27 (dq, J = 6.8, 49.6 Hz, 1H), 4.16 (s, 2H), 1.66 (dd, J = 6.8,23.6 Hz,
실시예Example 4 4 : 화학식 (2) 화합물의 합성(방법 B): Synthesis of Compound (2) (Method B)
실시예Example 4-1: 1-(3- 4-1: 1- (3- 이소프로필설파닐피리딘Isopropylsulfanylpyridine -2-일)-2-Yl) -2- 플루오로프로판Fluoropropane -1-온의 합성Synthesis of -1-one
2-브로모-3-이소프로필티오피리딘(4.72 g, 20 mmol)의 톨루엔(10 mL) 용액에 n-부틸 리튬(2.5 M 헥산 용액, 22 mmol)을 -70 ℃에서 적가하고 30 분 동안 더 교반한 후, 동일 온도를 유지하면서 반응액에 2-플루오로프로판산 모폴린아마이드 (3.28 g, 20 mmol)를 톨루엔에 희석하여 적가하였다. 반응이 완료되면 반응혼합물에 에탄올(2 mL)을 투입한 후 상온으로 승온하였다. 반응 혼합물을 6 N 염산(9 mL)과 증류수(6 mL) 순으로 유기층을 세척해 준 다음 감압증류하여 용매를 제거하였다. 증류가 완료되면 이소프로판올과 n-헥산으로부터 결정화하고 질소 하에서 건조하여 백색의 표제 화합물을 얻었다(3.22 g, 70%).N-Butyl lithium (2.5 M hexane solution, 22 mmol) was added dropwise to a toluene (10 mL) solution of 2-bromo-3-isopropylthiopyridine (4.72 g, 20 mmol) After stirring, 2-fluoropropanoic acid morpholine amide (3.28 g, 20 mmol) was diluted with toluene in the reaction solution while maintaining the same temperature. When the reaction was completed, ethanol (2 mL) was added to the reaction mixture, and the temperature was raised to room temperature. The organic layer was washed with 6 N hydrochloric acid (9 mL) and distilled water (6 mL), and the solvent was distilled off under reduced pressure. Upon completion of the distillation, crystallization from isopropanol and n-hexane and drying under nitrogen resulted in 3.22 g (70%) of the title compound.
1H NMR (CDCl3, δ): 8.38 (dd, J=1.2, 4.4 Hz, 1H), 7.78 (dd, J=1.2, 8.4 Hz, 1H), 7.23 (dd, J=4.4, 8.4 Hz, 1H), 6.25 (dq, J=8.0, 48.0 Hz, 1H), 3.52 (m, J=8.0 Hz, 1H), 1.65 (dd, J=8.0, 24.0 Hz, 3H), 1.41 (d, J=8.0 Hz, 3H), 1.39 (d, J=8.0 Hz, 3H)
1 H NMR (CDCl 3, δ ): 8.38 (dd, J = 1.2, 4.4 Hz, 1H), 7.78 (dd, J = 1.2, 8.4 Hz, 1H), 7.23 (dd, J = 4.4, 8.4 Hz, 1H ), 6.25 (dq, J = 8.0, 48.0 Hz, 1H), 3.52 (m, J = 8.0 Hz, 1H), 1.65 (dd, J = 8.0, 24.0 Hz, 3H), 1.41 (d, J = 8.0 Hz , 3H), 1.39 (d, J = 8.0 Hz, 3H)
다음은 화학식 (2)의 화합물을 종래의 방법에 의해 제조하는 것을 보여주는 비교예이다.The following is a comparative example showing the preparation of the compound of formula (2) by conventional methods.
비교예Comparative Example 1-1: 2- 1-1: 2- 시아노Cyano -3--3- 브로모피리딘의Bromopyridine 합성 synthesis
선행 특허문헌(US 5,354,749)의 방법을 그대로 적용하여3-브로모피리딘 (50.56 g, 320 mmol)으로부터 2 단계 반응을 거쳐 표제화합물을 얻었다(35.7 g, 195 mmol, 61%).The title compound was obtained (35.7 g, 195 mmol, 61%) from 3-bromopyridine (50.56 g, 320 mmol) by the same procedure of the prior patent document (US 5,354,749).
비교예Comparative Example 1-2: 2- 1-2: 2- 시아노Cyano -3--3- 이소프로필설파닐의Isopropylsulfanyl 합성 synthesis
소듐 하이드라이드(1.64 g, 41 mmol), 테트라하이드로푸란(150 mL), 이소프로판티올 (3.12 g, 41 mmol)의 혼합물을 1시간 동안 50 ℃에서 반응시켰다. 비교예 1-1에서 얻은2-시아노-3-브로모피리딘 (5.00 g, 27.3 mmol)을 위에서 얻은 테트라하이드로푸란 반응액에 투입한 후 1.5 시간 동안 환류하였다. 반응이 완결되면 테트라하이드로푸란 용매를 증류해내고 물과 톨루엔을 새로 투입하여 추출하였다. 추출된 유기층을 증류한 후, 헥산을 사용하여 결정화시켜 표제의 화합물을 얻었다(4.38 g, 24.5 mmol, 수율 90%).A mixture of sodium hydride (1.64 g, 41 mmol), tetrahydrofuran (150 mL), isopropanethiol (3.12 g, 41 mmol) was reacted at 50 ° C for 1 hour. 2-Cyano-3-bromopyridine (5.00 g, 27.3 mmol) obtained in Comparative Example 1-1 was added to the tetrahydrofuran reaction solution obtained above and refluxed for 1.5 hours. When the reaction was completed, the tetrahydrofuran solvent was distilled off, and water and toluene were newly added to the reaction mixture. The extracted organic layer was distilled and then crystallized using hexane to obtain the title compound (4.38 g, 24.5 mmol, 90% yield).
1H NMR (CDCl3, δ): 8.54 (dd, J=4.8, 1.8 Hz , 1 H), 7.84 (dd, J=8.0, 1.8 Hz, 1 H), 7.44 (dd, J=8.0, 4.8 Hz, 1 H) 3.57 (sep, J=6.7, 1 H), 1.37 (d, J=6.7 Hz, 6 H) 1 H NMR (CDCl3, δ) : 8.54 (dd, J = 4.8, 1.8 Hz, 1 H), 7.84 (dd, J = 8.0, 1.8 Hz, 1 H), 7.44 (dd, J = 8.0, 4.8 Hz, 1 H) 3.57 (sep, J = 6.7, 1 H), 1.37 (d, J = 6.7 Hz,
비교예Comparative Example 1-3: 1-(3- 1-3: 1- (3- 이소프로필설파닐피리딘Isopropylsulfanylpyridine -2-일)-2-Yl) -2- 플루오로프로판Fluoropropane -1-온의 합성Synthesis of -1-one
비교예 1-2에서 얻은 2-시아노-3-이소프로필설파닐(3.56 g, 20 mmol)로부터 선행 특허(JP 2003-335758)의 방법을 그대로 적용하여 3단계 반응을 거쳐 표제화합물을 얻었다(2.61 g, 11.5 mmol, 수율 58%).
The title compound was obtained from the 2-cyano-3-isopropylsulfanyl (3.56 g, 20 mmol) obtained in Comparative Example 1-2 by the same procedure as in the preceding patent (JP 2003-335758) 2.61 g, 11.5 mmol, yield 58%).
이상에서 살펴본 바와 같이, 본 발명에 따른 신규 피리딜 케톤 유도체 또는 2-브로모피리딘 유도체 화합물을 이용하는 방법에 의하면, 종래의 방법과 비교하여 훨씬 단순한 공정 단계를 통해 화학식 (2)의 화합물을 종래의 방법보다 높거나 동등 수준의 수율로 제조할 수 있다.As described above, the method using the novel pyridyl ketone derivative or the 2-bromopyridine derivative compound according to the present invention allows the compound of the formula (2) to be obtained by a conventional method Method can be produced at a higher or equivalent yield.
Claims (10)
[화학식 3]
상기 식에서,
D는 불소 또는 염소 원자를 나타내거나, S-A를 나타내며,
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타낸다.
E는 브롬 원자 또는 C(=O)CHYCH3 기를 나타내며,
Y는 불소, 염소, 브롬 원자를 나타낸다.A pyridine derivative compound represented by the following formula (3) for use in the production of flutosulfuron.
(3)
In this formula,
D represents a fluorine or chlorine atom, represents SA,
A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl .
E represents a bromine atom or a C (= O) CHYCH 3 group,
Y represents fluorine, chlorine or bromine atom.
[화학식 3a]
상기 식에서,
D는 불소 또는 염소를 나타내며
Y는 불소, 염소, 브롬 원자를 나타낸다.The pyridyl ketone derivative compound according to claim 1, which is represented by the following formula (3a).
[Chemical Formula 3]
In this formula,
D represents fluorine or chlorine
Y represents fluorine, chlorine or bromine atom.
[화학식 3b]
상기 식에서,
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타낸다.The 2-bromopyridine derivative compound according to claim 1, which is represented by the following formula (3b).
(3b)
In this formula,
A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl .
[화학식 3a]
[화학식 7]
[화학식 8]
상기 식에서,
D는 불소 또는 염소 원자를 나타내며,
Y는 불소, 염소 또는 브롬 원자를 나타내며,
W는 C1-C4-알콕시, C1-C4-다이알킬아민 또는 모폴린 기를 나타낸다.A process for the preparation of a compound of formula (VIII) according to claim 2, characterized in that a compound of formula (7) is reacted with n-butyl lithium and N, N- dimethylaminoethanol (DMAE) 3a). ≪ / RTI >
[Chemical Formula 3]
(7)
[Chemical Formula 8]
In this formula,
D represents a fluorine or chlorine atom,
Y represents a fluorine, chlorine or bromine atom,
W represents C 1 -C 4 -alkoxy, C 1 -C 4 -dialkylamine or a morpholine group.
[화학식 3b]
[화학식 10]
[화학식 11]
[화학식 12]
A-S-X
상기 식에서,
n = 0 또는 3을 나타내며,
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타내고,
X는 염소 원자 또는 S-A 기를 나타낸다.The compound of formula (3b) according to claim 4, wherein the compound of formula (10) is reacted with a strong base of a lithium amide of formula (11) and then reacted with an electrophile of formula (12) -Bromopyridine derivative compound.
(3b)
[Formula 10]
(11)
[Chemical Formula 12]
ASX
In this formula,
n = 0 or 3,
A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl Lt; / RTI >
X represents a chlorine atom or a SA group.
[화학식 12a]
A-S-S-A
상기 식에서,
n = 0 또는 3을 나타내며,
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타낸다.The process according to claim 7, wherein the electrophile compound of formula (12) is a compound of formula (12a).
[Formula 12a]
ASSA
In this formula,
n = 0 or 3,
A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl .
[화학식 3a]
[화학식 9]
A-SH
[화학식 2]
상기 식에서,
D는 불소 또는 염소 원자를 나타내며,
Y는 불소, 염소 또는 브롬 원자를 나타내며,
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타낸다.A process for preparing a compound of formula (2) which is a production intermediate of flutosulfuron, characterized by reacting a compound of formula (3a) with a compound of formula (9) under Cu catalyst, ligand, base and solvent.
[Chemical Formula 3]
[Chemical Formula 9]
A-SH
(2)
In this formula,
D represents a fluorine or chlorine atom,
Y represents a fluorine, chlorine or bromine atom,
A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl .
[화학식 3b]
[화학식 8]
[화학식 2]
상기 식에서,
W는 C1-C4-알콕시, C1-C4-다이알킬아민 또는 모폴린기를 나타내며,
Y는 불소, 염소 또는 브롬 원자를 나타내며,
A는 C3-C5-알킬, C3-C6사이클로알킬을 나타내거나, C1-C2-알킬 및 C1-C2-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타낸다.A process for the preparation of a compound of formula (2) which is a production intermediate of flutosulfuron, characterized by reacting a compound of formula (3b) with n-butyllithium followed by reaction with an electrophile of formula (8).
(3b)
[Chemical Formula 8]
(2)
In this formula,
W represents C 1 -C 4 -alkoxy, C 1 -C 4 -dialkylamine or a morpholine group,
Y represents a fluorine, chlorine or bromine atom,
A is C 3 -C 5 - alkyl, C 3 -C 6, or represent cycloalkyl, C 1 -C 2 - alkyl, and C 1 -C 2 - by a substituent selected from alkoxy of 1 to 5, a substituted or unsubstituted benzyl .
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20120076688 | 2012-07-13 | ||
KR1020120076688 | 2012-07-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140009016A true KR20140009016A (en) | 2014-01-22 |
KR101493488B1 KR101493488B1 (en) | 2015-02-16 |
Family
ID=49916340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR20130052600A KR101493488B1 (en) | 2012-07-13 | 2013-05-09 | Novel pyridine derivatives and method for preparation of intermediate compound for producing sulfonylurea herbicides using the same |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR101493488B1 (en) |
CN (1) | CN104487419B (en) |
WO (1) | WO2014010990A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101603324B1 (en) * | 2013-10-11 | 2016-03-14 | 주식회사 엘지생명과학 | Method for preparation of 3-alkylthio-2-bromopyridine |
CN104829524A (en) * | 2014-02-11 | 2015-08-12 | Fmc公司 | Synthetic method of intermediate of herbicide flucetosulfuron |
UY36548A (en) | 2015-02-05 | 2016-06-01 | Bayer Cropscience Ag | BICYCLIC CONDENSED HETEROCYCLIC DERIVATIVES REPLACED BY 2- (HET) ARILO AS PESTICIDES |
EP3581565A1 (en) * | 2018-06-14 | 2019-12-18 | Beijing Zhibo Bio-Medical Technology Co., Ltd. | Phenyl benzyl ether derivative and preparation method and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100641908B1 (en) * | 2002-05-02 | 2006-11-02 | 주식회사 엘지생명과학 | Pyridine derivatives, process for the preparation thereof, and use as an intermediate of herbicides |
JP3880883B2 (en) * | 2002-05-20 | 2007-02-14 | エルジー ケム インヴェストメント リミティッド | Pyridine derivatives, methods for producing the same, and uses as herbicide intermediates |
US7291631B2 (en) * | 2003-04-11 | 2007-11-06 | Genzyme Corporation | CXCR4 chemokine receptor binding compounds |
-
2013
- 2013-05-09 KR KR20130052600A patent/KR101493488B1/en active IP Right Grant
- 2013-07-12 WO PCT/KR2013/006269 patent/WO2014010990A1/en active Application Filing
- 2013-07-12 CN CN201380037273.7A patent/CN104487419B/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2014010990A1 (en) | 2014-01-16 |
KR101493488B1 (en) | 2015-02-16 |
CN104487419B (en) | 2016-08-24 |
CN104487419A (en) | 2015-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5318037B2 (en) | Process for producing pyrimidine compounds | |
JP7539451B2 (en) | Improved process for preparing aminopyrimidine derivatives | |
KR101493488B1 (en) | Novel pyridine derivatives and method for preparation of intermediate compound for producing sulfonylurea herbicides using the same | |
NO314456B1 (en) | Methods and intermediates useful for preparing antifolates | |
JP2011500796A (en) | New precursor | |
WO2013092463A1 (en) | 4-azaindole inhibitors of crac | |
CA2086210A1 (en) | .beta.-oxo-.beta.-benzenepropanethioamide derivatives | |
KR102684954B1 (en) | Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same | |
KR20150095785A (en) | Process for the preparation of 4-amino-5-fluoro-3-chloro-6-(substitu ted)picolinates | |
DE60103752T2 (en) | PROCESS FOR PREPARING PYRAZOLOPYRIDINE DERIVATIVES | |
JP3720637B2 (en) | New nitroisourea derivatives | |
JP2004525927A (en) | Method for producing lansoprazole and its intermediate | |
JP2552905B2 (en) | N-[(2-oxo-1-pyrrolidinyl) acetyl] piperazine derivative, method for producing the same and senile dementia drug | |
JP4176163B2 (en) | Process for producing 1-{[2- (cyclopropylcarbonyl) phenyl] sulfamoyl} -3- (4,6-dialkoxy-2-pyrimidinyl) urea compound and intermediate for the production | |
DE10063106A1 (en) | Process for the preparation of 2- (2-ethoxyphenyl) substituted imidazotriazinones | |
JP2003286285A (en) | Method for producing pyridone compound and intermediate for the same | |
SK4202000A3 (en) | Process of making 3-aryloxy-4-aryl furan-2-ones useful as inhibitors of cox-2 | |
JPH06774B2 (en) | Method for producing pyrrole derivative | |
JPH05294942A (en) | Production of 3@(3754/24)2h)-pyridazinone derivative | |
JP2003335757A (en) | Method for producing ether compound | |
JP2008266176A (en) | METHOD FOR PRODUCING alpha-PYRONE COMPOUND | |
JPWO2002076962A1 (en) | Method for producing 3-oxo-2- (2-thiazolyl) propanenitrile and intermediate | |
JPS6377849A (en) | Manufacture of substituted amide derivative | |
JPH08333344A (en) | Naphthoic ester derivative and its production | |
WO2001005775A1 (en) | Process for the preparation of substituted benzisothiazole compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
FPAY | Annual fee payment |
Payment date: 20180116 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20190116 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20200116 Year of fee payment: 6 |